21-hydroxylase deficiency detected in neonatal screening: high probability of false negativity in late onset form
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F25%3A43927611" target="_blank" >RIV/00064173:_____/25:43927611 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/25:43927611 RIV/65269705:_____/25:00080440 RIV/75010330:_____/25:00014943
Result on the web
<a href="https://doi.org/10.1055/a-2433-0891" target="_blank" >https://doi.org/10.1055/a-2433-0891</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1055/a-2433-0891" target="_blank" >10.1055/a-2433-0891</a>
Alternative languages
Result language
angličtina
Original language name
21-hydroxylase deficiency detected in neonatal screening: high probability of false negativity in late onset form
Original language description
AIM: Despite the high sensitivity of neonatal screening in detecting the classical form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, one of the unclear issues is identifying asymptomatic children with late onset forms. The aim of this nationwide study was to analyse the association between genotype and screened level of 17-hydroxyprogesterone in patients with the late onset form of 21-hydroxylase deficiency and to quantify false negativity. METHODS: In the Czech Republic, 1,866,129 neonates were screened (2006-2022). Among this cohort, 159 patients were confirmed to suffer from 21-hydroxylase deficiency, employing the 17-hydroxyprogesterone birthweight/gestational age-adjusted cut-off limits, and followed by the genetic confirmation. The screening prevalence was 1:11,737. Another 57 patients who were false negative in neonatal screening were added to this cohort based on later diagnosis by clinical suspicion. To our knowledge, such a huge nationwide cohort of false negative patients has not been documented before. RESULTS: Overall, 57 patients escaped from neonatal screening in the monitored period. All false negative patients had milder forms. Only one patient had simple virilising form and 56 patients had the late onset form. The probability of false negativity in the late onset form was 76.7%. The difference in 17-hydroxyprogesterone screening values was statistically significant (p < 0.001) between severe forms (median 478,8 nmol/L) and milder (36,2 nmol/L) forms. Interestingly, the higher proportion of females with milder forms was statistically significant compared with the general population. CONCLUSIONS: A negative neonatal screening result does not exclude milder forms of 21-hydroxylase deficiency during the differential diagnostic procedure of children with precocious pseudopuberty.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30209 - Paediatrics
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Experimental and Clinical Endocrinology & Diabetes
ISSN
0947-7349
e-ISSN
1439-3646
Volume of the periodical
133
Issue of the periodical within the volume
1
Country of publishing house
DE - GERMANY
Number of pages
5
Pages from-to
20-24
UT code for WoS article
001353389600001
EID of the result in the Scopus database
2-s2.0-85209731151